AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,487,566 | -27.9% | 191,450 | -10.2% | 0.00% | -100.0% |
| Q2 2023 | $2,063,932 | +4.3% | 213,216 | +18.1% | 0.00% | 0.0% |
| Q1 2023 | $1,978,258 | +200.0% | 180,498 | +18.2% | 0.00% | – |
| Q4 2022 | $659,418 | -74.9% | 152,643 | -56.3% | 0.00% | -100.0% |
| Q3 2022 | $2,628,000 | -31.0% | 349,428 | -7.8% | 0.00% | 0.0% |
| Q2 2022 | $3,808,000 | -36.0% | 378,888 | -21.2% | 0.00% | -50.0% |
| Q1 2022 | $5,953,000 | -47.6% | 480,901 | -3.2% | 0.00% | -33.3% |
| Q4 2021 | $11,365,000 | -11.3% | 496,993 | -14.1% | 0.00% | 0.0% |
| Q3 2021 | $12,810,000 | +25.4% | 578,874 | -26.6% | 0.00% | +50.0% |
| Q2 2021 | $10,216,000 | +3.0% | 788,283 | +3.2% | 0.00% | 0.0% |
| Q1 2021 | $9,918,000 | +7.6% | 763,821 | +14.6% | 0.00% | 0.0% |
| Q4 2020 | $9,219,000 | +65.4% | 666,597 | +76.2% | 0.00% | 0.0% |
| Q3 2020 | $5,573,000 | +94.3% | 378,347 | +114.4% | 0.00% | +100.0% |
| Q2 2020 | $2,868,000 | -52.5% | 176,467 | -57.6% | 0.00% | -50.0% |
| Q1 2020 | $6,034,000 | +272.5% | 415,853 | +419.9% | 0.00% | – |
| Q4 2019 | $1,620,000 | +289.4% | 79,993 | +2.6% | 0.00% | – |
| Q3 2019 | $416,000 | -18.9% | 77,993 | 0.0% | 0.00% | – |
| Q2 2019 | $513,000 | +37.2% | 77,993 | +35.5% | 0.00% | – |
| Q1 2019 | $374,000 | +6133.3% | 57,561 | +6818.4% | 0.00% | – |
| Q4 2018 | $6,000 | -94.7% | 832 | -95.2% | 0.00% | – |
| Q3 2018 | $114,000 | +5.6% | 17,224 | -10.6% | 0.00% | – |
| Q2 2018 | $108,000 | -14.3% | 19,260 | -20.5% | 0.00% | – |
| Q1 2018 | $126,000 | +41.6% | 24,217 | +23.6% | 0.00% | – |
| Q4 2017 | $89,000 | -46.4% | 19,595 | -26.3% | 0.00% | – |
| Q3 2017 | $166,000 | +16500.0% | 26,595 | +13197.5% | 0.00% | – |
| Q2 2017 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |